Page last updated: 2024-09-03

reboxetine and Acute Relapsing Multiple Sclerosis

reboxetine has been researched along with Acute Relapsing Multiple Sclerosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Becker, GA; Haars, S; Hesse, S; Hoffmann, KT; Lobsien, D; Luthardt, J; Rullmann, M; Sabri, O; Schinke, C; Schmidt, E; Stoppe, M; Then Bergh, F	1

Other Studies

1 other study(ies) available for reboxetine and Acute Relapsing Multiple Sclerosis

Article	Year
Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients. Scientific reports, 2020, 09-04, Volume: 10, Issue:1 Topics: Adult; Brain; Carbon Radioisotopes; Depression; Disability Evaluation; Fatigue; Female; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reboxetine; Young Adult	2020

Article

Year

Changes of central noradrenaline transporter availability in immunotherapy-naïve multiple sclerosis patients.

Scientific reports, 2020, 09-04, Volume: 10, Issue:1

Topics: Adult; Brain; Carbon Radioisotopes; Depression; Disability Evaluation; Fatigue; Female; Humans; Immunotherapy; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Positron-Emission Tomography; Psychiatric Status Rating Scales; Reboxetine; Young Adult

2020